Return to A-Z Topics List »

A-Z Topics

The Alzheimer Society of Canada defines dementia as an overall term for a set of symptoms that are caused by disorders affecting the brain. Symptoms may include memory loss and difficulties with thinking, problem-solving, or language that are severe enough to reduce a person’s ability to perform everyday activities.

Many diseases can cause dementia, the most common being Alzheimer’s disease and vascular dementia (due to strokes). It is estimated that about 564,000 Canadians are currently living with dementia, and that 937,000 will be living with the disease 15 years from now.

CFHI supports innovations that are improving care for people with dementia across the country, including the Appropriate Use of Antipsychotics (AUA) approach.

In May 2014, CFHI designed and launched its first pan-Canadian AUA collaborative, working with 56 long term care homes – in seven provinces and one territory – to cut the inappropriate prescribing of antipsychotic medication to seniors residing in long term care.

This collaborative had its roots in an innovation implemented through the EXTRA: Executive Training Program.

In 2016, New Brunswick was the first province to work with us to scale the AUA approach with the New Brunswick Appropriate Use of Antipsychotics (NB-AUA) collaborative.

In 2017, we announced that we would be supporting Quebec in its own province-wide scale, Optimizing Practices, Uses, Care and Services—Antipsychotics (OPUS-AP).

In 2018, we’re scaling the collaborative in Prince Edward Island, and in Newfoundland and Labrador.  

Learn more about CFHI's work in spreading and scaling the AUA approach across Canada »